Dysfunctional islet amyloid polypeptide (IAPP) biosynthesis and/or processing are thought contributeto formation of islet amyloid in type 2 diabetes. However, it is unclear how normal pro-IAPP biosynthesis and processing are regulated to be able to define such dysfunction. Here, it was found that acute exposure to high glucose concentrations coordinately regulated the biosynthesis of pro-IAPP, proinsulin, and its proprotein convertase PC1β in normal isolated rat islets, without affecting their respective mRNA levels. Pro-7B2 biosynthesis, like that of pro-PC2, did not appreciably change, but this was likely due to a much higher expression in pancreatic α-cells masking glucose regulation of their biosynthesis in β-cells. Biosynthesis of pro-SAAS, the putative PC1β chaperone, was unaffected by glucose, consistent with its scarce expression in β-cells. We conclude that translational control of pro-IAPP biosynthesis, in parallel to the pro-PC1β, pro-PC2, and pro-7B2 proprotein-processing endopeptidases/ chaperones, is the predominate mechanism to produce IAPP in islet β-cells. © 2012 by The Endocrine Society.
CITATION STYLE
Alarcon, C., Verchere, C. B., & Rhodes, C. J. (2012). Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. Endocrinology, 153(5), 2082–2087. https://doi.org/10.1210/en.2011-2019
Mendeley helps you to discover research relevant for your work.